UBS (Lux) Digital Health Equity Fund IBH

Reference Data

ISIN LU2289394632
Valor Number 59412744
Bloomberg Global ID
Fund Name UBS (Lux) Digital Health Equity Fund IBH
Fund Provider Credit Suisse Fund Management S.A. Zürich, Switzerland
Phone: +41 44 333 40 50
E-Mail: clientservices.amfunds@credit-suisse.com
Web: www.credit-suisse.com
Fund Provider Credit Suisse Fund Management S.A.
Representative in Switzerland UBS Fund Management (Switzerland) AG
Basel
Phone: +41 61 288 49 10
Distributor(s) UBS AG
Basel
Phone: +41 61 288 75 01
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The objective of the Subfund is to achieve the highest possible return in US dollars (Reference Currency), while taking due account of the principle of risk diversification, the security of the capital invested, and the liquidity of the assets. This Subfund aims to outperform the return of the MSCI World ESG Leaders (NR) benchmark. The Subfund is actively managed. The benchmark is used as a reference point for portfolio construction and as a basis for setting risk constraints, and/or for Performance Fee measurement purposes. The majority of the Subfund’s equity securities will not necessarily be components of or have weightings derived from the benchmark. The Investment Manager will use its discretion to significantly deviate the weighting of certain components of the benchmark and to significantly invest in companies or sectors not included in the benchmark in order to take advantage of specific investment opportunities.
Peculiarities

Fund Prices

Current Price * 488.27 GBP 03.10.2024
Previous Price * 497.38 GBP 02.10.2024
52 Week High * 530.80 GBP 27.02.2024
52 Week Low * 370.06 GBP 30.10.2023
NAV * 488.27 GBP 03.10.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 837,334,694
Unit/Share Assets *** 1,049,900
Trading Information SIX

Performance

YTD Performance -2.86% 29.12.2023
03.10.2024
YTD Performance (in CHF) +1.46% 29.12.2023
03.10.2024
1 month +0.52% 03.09.2024
03.10.2024
3 months +7.45% 03.07.2024
03.10.2024
6 months -0.39% 03.04.2024
03.10.2024
1 year +16.12% 03.10.2023
03.10.2024
2 years +0.97% 03.10.2022
03.10.2024
3 years -41.11% 04.10.2021
03.10.2024
5 years -51.17% 29.01.2021
03.10.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Zai Lab Ltd Ordinary Shares 4.26%
Veeva Systems Inc Class A 3.84%
Schrodinger Inc Ordinary Shares 3.83%
Zealand Pharma A/S 3.82%
Redcare Pharmacy NV 3.80%
Twist Bioscience Corp 3.59%
Inspire Medical Systems Inc 3.51%
Natera Inc 3.38%
TransMedics Group Inc 3.36%
Exact Sciences Corp 3.14%
Last data update 31.07.2024

Cost / Risk

TER 1.24%
TER date 31.05.2024
Performance Fee ***
PTR
Max. Management Fee *** 0.90%
Ongoing Charges *** 1.24%
SRRI ***
SRRI date ***

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)